Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncogene

• Publication date

  2002-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1205390PMID 12082530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex.

  2001influential reference
• Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.

  2001cited by this paper
• The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification*

  2001cited by this paper
• Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

  2000cited by this paper
• SUMO--nonclassical ubiquitin.

  2000cited by this paper
• Regulation of the Cdk inhibitor p27 and its deregulation in cancer

  2000cited by this paper
• Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.

  2000cited by this paper
• Oncogenic Signals of HER-2/neu in Regulating the Stability of the Cyclin-dependent Kinase Inhibitor p27*

  2000cited by this paper
• p38 JAB1 Binds to the Intracellular Precursor of the Lutropin/Choriogonadotropin Receptor and Promotes Its Degradation*

  2000cited by this paper
• All in the Ubiquitin Family

  2000cited by this paper
• The nuclear DEAD box RNA helicase p68 interacts with the nucleolar protein fibrillarin and colocalizes specifically in nascent nucleoli during telophase.

  2000cited by this paper
• Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.

  2000cited by this paper
• Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

  2000cited by this paper
• The ubiquitin‐mediated proteolytic pathway: Mode of action and clinical implications

  2000cited by this paper
• Down‐regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas

  2000cited by this paper
• Deubiquitinating enzymes: their diversity and emerging roles.

  1999cited by this paper
• PGP9.5 as a candidate tumor marker for non-small-cell lung cancer.

  1999cited by this paper
• Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

  1999cited by this paper
• A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits

  1998influential reference
• Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.

  1998cited by this paper
• Modification of Ran GTPase-activating Protein by the Small Ubiquitin-related Modifier SUMO-1 Requires Ubc9, an E2-type Ubiquitin-conjugating Enzyme Homologue*

  1998cited by this paper
• The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex.

  1998cited by this paper
• Cleavage of the C-terminus of NEDD8 by UCH-L3.

  1998cited by this paper
• Deubiquitinating enzymes: a new class of biological regulators.

  1998cited by this paper
• The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus

  1997cited by this paper
• Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes

  1997cited by this paper
• Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast.

  1996cited by this paper
• A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

  1996influential reference
• Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.

  1996influential reference
• Studies on the transformation of intact yeast cells by the LiAc/SS‐DNA/PEG procedure

  1995cited by this paper
• A cell cycle-regulated inhibitor of cyclin-dependent kinases.

  1994cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994influential reference

• Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders

  2023cites this paper
• A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase

  2022cites this paper
• UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target.

  2021cites this paper
• Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis

  2021cites this paper
• Mutation of a ubiquitin carboxy terminal hydrolase L1 lipid binding site alleviates cell death, axonal injury, and behavioral deficits after traumatic brain injury in mice.

  2021cites this paper
• Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

  2020cites this paper
• In silico analysis of hypermethylation in CpGislands of UCHL1 gene’s promoter in nasopharyngeal carcinoma

  2020cites this paper
• VCP/p97 targets the nuclear export and degradation of p27Kip1 during G1 to S phase transition

  2020cites this paper
• Gene UCHL1 expresses specifically in mouse uterine decidual cells in response to estrogen

  2020cites this paper
• Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells

  2019cites this paper
• New insights into the gene expression associated to amyotrophic lateral sclerosis.

  2018cites this paper
• Model in the Study Role of UCH-L 1 Dang

  2018cites this paper
• Drosophila Model in the Study Role of UCH-L1

  2018cites this paper
• Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27kip1 to drive hepatocellular carcinoma progression.

  2017cites this paper
• Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery

  2017cites this paper
• Single‐cell RNA sequencing reveals an altered gene expression pattern as a result of CRISPR/cas9‐mediated deletion of Gene 33/Mig6 and chronic exposure to hexavalent chromium in human lung epithelial cells

  2017cites this paper
• Prognostic potential and oncogenic effects of UCH-L1 expression in hilar cholangiocarcinoma.

  2017cites this paper
• Cyclin B1 mediates the effect of UCHL1 in promoting cell cycle progression in uterine papillary serous carcinoma

  2017cites this paper
• Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications

  2017cites this paper
• Protein Gene Product 9.5 Expression in Stallion Testes

  2016cites this paper
• Overexpression of ubiquitin carboxyl terminal hydrolase‐L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway

  2016cites this paper
• Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease

  2015cites this paper
• Cell Death and Deubiquitinases: Perspectives in Cancer

  2014cites this paper
• Uchl1 and its associated proteins were involved in spermatocyte apoptosis in mouse experimental cryptorchidism.

  2014cites this paper
• Ubiquitin carboxyl hydrolase L1 significance for human diseases.

  2014cites this paper
• UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.

  2014cites this paper
• Winter Hibernation and UCHL1-p34cdc2 Association in Toad Oocyte Maturation Competence

  2013cites this paper
• Could Dysregulation of UPS be a Common Underlying Mechanism for Cancer and Neurodegeneration? Lessons from UCHL1

  2013cites this paper
• Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Acts as a Novel Potentiator of Cyclin-dependent Kinases to Enhance Cell Proliferation Independently of Its Hydrolase Activity*

  2013cites this paper
• Molecular diagnosis of parathyroid carcinoma: a reality in the near future.

  2012cites this paper
• Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis

  2012cites this paper
• Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions

  2011cites this paper
• Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation

  2011cites this paper
• UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.

  2011cites this paper
• UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein.

  2010influential citation
• JAB1/CSN5: a new player in cell cycle control and cancer

  2010cites this paper
• Ubiquitin-Dependent Protein Degradation

  2010cites this paper
• 5.21 – Ubiquitin-Dependent Protein Degradation

  2010cites this paper
• Post-translational modification of cellular proteins by ubiquitin and ubiquitin-like molecules: role in cellular senescence and aging.

  2010cites this paper
• Role of Ubiquitin C-Terminal Hydrolase-L1 in Antipolyspermy Defense of Mammalian Oocytes1

  2010cites this paper
• The ubiquitin C‐terminal hydrolase UCH‐L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton

  2010influential citation
• Expression of USP2‐69 in mesangial cells in vivo and in vitro

  2010cites this paper
• Ubiquitin C-terminal Hydrolase-L1 Protects Cystic Fibrosis Transmembrane Conductance Regulator from Early Stages of Proteasomal Degradation*

  2010cites this paper
• The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma

  2010cites this paper
• The potential role of ubiquitin c-terminal hydrolases in oncogenesis.

  2010cites this paper
• Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.

  2009cites this paper
• Regulation of Synaptic Structure by Ubiquitin C-Terminal Hydrolase L1

  2009cites this paper
• Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.

  2009cites this paper
• Ubiquitin carboxyl-terminal hydrolase L1 contributes to the oocyte selective elimination in prepubertal mouse ovaries.

  2009cites this paper
• Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling

  2009cites this paper
• Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma

  2009cites this paper
• Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis

  2009cites this paper
• DNA damage tolerance in mammalian cells

  2009cites this paper
• Expression and Functional Studies of Ubiquitin C-Terminal Hydrolase L1 Regulated Genes

  2009cites this paper
• The ubiquitin C‐terminal hydrolase UCH‐L1 regulates B‐cell proliferation and integrin activation

  2009cites this paper
• Mammalian COP9 signalosome

  2009cites this paper
• UCH‐L1 expression of podocytes in diseased glomeruli and in vitro

  2009cites this paper
• Protein partners of deubiquitinating enzymes.

  2008cites this paper
• Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.

  2008cites this paper
• The Deubiquitinating Enzymes

  2008cites this paper
• Downregulation of two isoforms of ubiquitin carboxyl‐terminal hydrolase isozyme L1 correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones

  2008cites this paper
• Acute damage by naphthalene triggers expression of the neuroendocrine marker PGP9.5 in airway epithelial cells.

  2008cites this paper
• The COP9 Signalosome and Its Role in the Ubiquitin System

  2008cites this paper
• Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer

  2008cites this paper
• Ubiquitin COOH-Terminal Hydrolase 1: A Biomarker of Renal Cell Carcinoma Associated with Enhanced Tumor Cell Proliferation and Migration[?Q1: Running head: UCHL1, a Biomarker of RCC. Short title OK?Q1]

  2007cites this paper
• The functions of UCH-L1 and its relation to neurodegenerative diseases.

  2007cites this paper
• Emerging roles of deubiquitinating enzymes in human cancer

  2007cites this paper
• A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis

  2007cites this paper
• Proteomic and transcriptomic analysis of human CD8+ T lymphocytes over‐expressing telomerase

  2007cites this paper
• Expression of Ubiquitin Carboxy-Terminal Hydrolase-L1 in Photocoagulated Human Retinal Pigment Epithelial Cells

  2007cites this paper
• Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-&kgr;B Activation

  2007cites this paper
• Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors.

  2007cites this paper
• Proteomic analysis of protein expression changes in a model of gliomagenesis

  2007cites this paper
• alpha-Synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity.

  2007cites this paper
• Reversible Monoubiquitination Regulates the Parkinson Disease-associated Ubiquitin Hydrolase UCH-L1*♦

  2007cites this paper
• Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A

  2007cites this paper
• MODULATION OF THE DEUBIQUITINATING SYSTEM IN VIRAL INFECTION, LYMPHOID CELL ACTIVATION AND MALIGNANT TRANSFORMATION

  2007influential citation
• The COP9 Signalosome: Structural and Biochemical Conservation and Its Roles in the Regulation of Plant Development

  2007cites this paper
• The Ubiquitin–Proteasome System in Epstein‐Barr Virus Infection and Oncogenesis

  2007cites this paper
• Overexpression of jun activation domain‐binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features

  2006cites this paper
• Functional facets of the pulmonary neuroendocrine system

  2006cites this paper
• High expression of ubiquitin carboxy‐terminal hydrolase‐L1 and ‐L3 mRNA predicts early recurrence in patients with invasive breast cancer

  2006cites this paper
• Mechanistic studies of ubiquitin C-terminal hydrolase L1.

  2006cites this paper
• Tumours and tremors: how PTEN regulation underlies both

  2006cites this paper
• Oxidative stress regulated expression of Ubiquitin Carboxyl-terminal Hydrolase-L1: Role in cell survival

  2006cites this paper
• Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains

  2006cites this paper
• Aging and the ubiquitinome: traditional and non-traditional functions of ubiquitin in aging cells and tissues.

  2006cites this paper
• Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers.

  2006influential citation
• Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features

  2006cites this paper
• Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines

  2006cites this paper
• Developmental study of tethered spinal cord in murine embryos with anorectal malformations.

  2005cites this paper
• The Emerging Role of the COP9 Signalosome in Cancer

  2005cites this paper
• COPing with hypoxia.

  2005cites this paper
• Gene expression in midgut carcinoid tumors: Potential targets for immunotherapy

  2005cites this paper
• Olfactory epithelia differentially express neuronal markers

  2005cites this paper
• APPROACHES TO CHARACTERIZE UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 BY PROTEOLYTIC MAPPING

  2005cites this paper
• To die or grow: Parkinson's disease and cancer.

  2005cites this paper
• The Emerging Role of the COP 9 Signalosome in Cancer

  2005cites this paper
• Tumor‐induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors

  2005cites this paper
• Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines.

  2005cites this paper